Colin Walsh - Jun 17, 2022 Form 4 Insider Report for Elevation Oncology, Inc. (ELEV)

Role
Director
Signature
/s/ Tammy Furlong, Attorney-in-Fact
Stock symbol
ELEV
Transactions as of
Jun 17, 2022
Transactions value $
$0
Form type
4
Date filed
6/22/2022, 06:45 PM
Previous filing
Jun 24, 2021
Next filing
Jun 21, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELEV Stock Option (Right to Buy) Award $0 +15.6K $0.00 15.6K Jun 17, 2022 Common Stock 15.6K $1.31 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The entire award will vest on the one year anniversary of the grant date, subject to the reporting person's continued service to the Issuer on such date.